The Food and Drug Administration (FDA) recommend that doctors only prescribe fluticasone and salmeterol if other medications are ineffective in controlling a person’s symptoms
Some brands are used to treat COPD (chronic obstructive pulmonary disease)
[9] Salmeterol is ten times more potent
1K
Use WIXELA INHUB with caution in patients taking non–potassium-sparing diuretics (such as loop or thiazide diuretics), as electrocardiographic changes and/or hypokalemia
Contraindications
Oral administration of salmeterol at a dose of 10,000 mcg/kg/day to lactating rats resulted in measurable levels in milk
Food and Drug Administration
Children 4 years of age and older—At first, 1 spray in each nostril once a day
If you are using more than 1 inhaled drug, ask the doctor which drug to use first
Bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs
Children 4 to 11 years of age—30 mcg 2 times a day (about 12 hours apart)
It works by relaxing muscles in the airways to improve breathing
How the dose, route, and duration of corticosteroid administration affect the risk of developing a disseminated infection is not known; Learn about ADVAIR for the treatment of asthma and ADVAIR DISKUS 250/50 for COPD, including risks and side effects
AirDuo RespiClick; Authorized Generic (BMD): Decreases in BMD have been observed with long-term administration of products containing ICS
Long-acting beta 2-adrenergic agonists (LABA), such as salmeterol, one of the active ingredients in ADVAIR DISKUS®, increase the risk of asthma-related death
AirDuo Digihaler should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled
Strengths: 100 mcg fluticasone/50 mcg salmeterol, 250 mcg fluticasone/50 mcg salmeterol, 500 mcg fluticasone/50 mcg salmeterol Adult dosage (ages 18–64 years) AirDuo Digihaler is a combination of fluticasone propionate, a corticosteroid, and salmeterol, a long-acting beta 2-adrenergic agonist (LABA), indicated for treatment of asthma in patients aged 12 years and older
Design: Randomized, double-blind, triple-dummy, multicenter, 12-week clinical trial
Shake the oral aerosol inhaler well for 5 seconds before each inhalation